ResearcherUniversity of RochesterActive in the last 2 years
Anthony Casabianca
Matched on ORCID iD 0000-0003-0416-2288; OpenAlex author ID A5035769625. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 25
2020: 1 paper · 2021: none · 2022: 1 paper · 2023: 1 paper · 2024: 1 paper · 2025: none · 2026: 1 paper
Papers 5
- The circadian gene Dec2 promotes pancreatic cancer progression and dormancy through immune evasion. Co-author DOI 10.1016/j.devcel.2026.04.001↗
- Protocol for isolating extracellular vesicles from pancreatic cancer cells for liver metastatic niche research. Co-author DOI 10.1016/j.xpro.2024.103256↗
- Netrin-1 feedforward mechanism promotes pancreatic cancer liver metastasis via hepatic stellate cell activation, retinoid, and ELF3 signaling. First author DOI 10.1016/j.celrep.2023.113369↗
- The Impact of Carbohydrate Antigen 19-9 on Survival in Patients with Clinical Stage I and II Pancreatic Cancer. Co-author DOI 10.1245/s10434-022-12497-x↗
- A Novel Model of Pancreatic Cancer Dormancy Reveals Mechanistic Insights and a Dormancy Gene Signature with Human Relevance Co-author DOI 10.1101/2020.04.13.037374↗
Closest collaborators
The 25 strongest of 25 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Darren R. Carpizo · 5 shared papers, 2020–2026 · strength 0.77
- Paper The circadian gene Dec2 promotes pancreatic cancer progression and dormancy through immune evasion. DOI 10.1016/j.devcel.2026.04.001↗
- Paper Protocol for isolating extracellular vesicles from pancreatic cancer cells for liver metastatic niche research. DOI 10.1016/j.xpro.2024.103256↗
- Paper The Impact of Carbohydrate Antigen 19-9 on Survival in Patients with Clinical Stage I and II Pancreatic Cancer. DOI 10.1245/s10434-022-12497-x↗
- Crissy Dudgeon · 4 shared papers, 2020–2026 · strength 0.63
- Paper The circadian gene Dec2 promotes pancreatic cancer progression and dormancy through immune evasion. DOI 10.1016/j.devcel.2026.04.001↗
- Paper Protocol for isolating extracellular vesicles from pancreatic cancer cells for liver metastatic niche research. DOI 10.1016/j.xpro.2024.103256↗
- Paper Netrin-1 feedforward mechanism promotes pancreatic cancer liver metastasis via hepatic stellate cell activation, retino… DOI 10.1016/j.celrep.2023.113369↗
- Subhajyoti De · 3 shared papers, 2020–2026 · strength 0.44
- Paper The circadian gene Dec2 promotes pancreatic cancer progression and dormancy through immune evasion. DOI 10.1016/j.devcel.2026.04.001↗
- Paper Netrin-1 feedforward mechanism promotes pancreatic cancer liver metastasis via hepatic stellate cell activation, retino… DOI 10.1016/j.celrep.2023.113369↗
- Paper A Novel Model of Pancreatic Cancer Dormancy Reveals Mechanistic Insights and a Dormancy Gene Signature with Human Relev… DOI 10.1101/2020.04.13.037374↗
- Patrick Mehlen · 2 shared papers, 2023–2024 · strength 0.33
- Paper Protocol for isolating extracellular vesicles from pancreatic cancer cells for liver metastatic niche research. DOI 10.1016/j.xpro.2024.103256↗
- Paper Netrin-1 feedforward mechanism promotes pancreatic cancer liver metastasis via hepatic stellate cell activation, retino… DOI 10.1016/j.celrep.2023.113369↗
- Igor A. Astsaturov · 2 shared papers, 2023–2024 · strength 0.33
- Paper Protocol for isolating extracellular vesicles from pancreatic cancer cells for liver metastatic niche research. DOI 10.1016/j.xpro.2024.103256↗
- Paper Netrin-1 feedforward mechanism promotes pancreatic cancer liver metastasis via hepatic stellate cell activation, retino… DOI 10.1016/j.celrep.2023.113369↗
- Paula M. Vertino · 2 shared papers, 2020–2026 · strength 0.30
- Mihir Maheshkumar Shah · 2 shared papers, 2020–2022 · strength 0.24
- Paper The Impact of Carbohydrate Antigen 19-9 on Survival in Patients with Clinical Stage I and II Pancreatic Cancer. DOI 10.1245/s10434-022-12497-x↗
- Paper A Novel Model of Pancreatic Cancer Dormancy Reveals Mechanistic Insights and a Dormancy Gene Signature with Human Relev… DOI 10.1101/2020.04.13.037374↗
- Lan Wang · 1 shared paper, 2026 · strength 0.20
- Anna Bianchi · 1 shared paper, 2026 · strength 0.20
- Jean L. Grem · 1 shared paper, 2026 · strength 0.20
- Brian James Altman · 1 shared paper, 2026 · strength 0.20
- Michael Anthony Hollingsworth · 1 shared paper, 2026 · strength 0.20
- Paul M. Grandgenett · 1 shared paper, 2026 · strength 0.20
- Brian B. Haab · 1 shared paper, 2026 · strength 0.20
- Jashodeep Datta · 1 shared paper, 2026 · strength 0.20
- Muhammad Sadeqi Nezhad · 1 shared paper, 2024 · strength 0.19
- David A. Kooby · 1 shared paper, 2022 · strength 0.15
- Alexa D. Melucci · 1 shared paper, 2022 · strength 0.15
- Debora Barbosa Vendramini Costa · 1 shared paper, 2023 · strength 0.14
- Charline Ogier · 1 shared paper, 2023 · strength 0.14
- Aram F. Hezel · 1 shared paper, 2023 · strength 0.14
- Jason Robert Pitarresi · 1 shared paper, 2023 · strength 0.14
- Vinod P. Balachandran · 1 shared paper, 2020 · strength 0.10
- Bassel Ghaddar · 1 shared paper, 2020 · strength 0.10
- Eric Andrew Collisson · 1 shared paper, 2020 · strength 0.10
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.